CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Study of Concomitant Fluorouracil, Hydroxyurea, Cetuximab and Hyperfractionated Intensity Modulated Radiation Therapy for Locally Advanced Head and Neck Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00462735
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:59.245940+00:00
Published At: 2018-03-13T00:00:00+00:00
Record Updated At: 2018-03-13
Results Posted At: 2018-03-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Head and Neck Cancer", "Cancer of the Pharynx", "Cancer of the Larynx", "Nose Neoplasms", "Paranasal Sinus Neoplasms", "Cancer of the Oral Cavity"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-03-13"
protocolSection.identificationModule.nctId: "NCT00462735"
protocolSection.identificationModule.officialTitle: "Phase II Study of Concomitant Fluorouracil, Hydroxyurea, Cetuximab and Hyperfractionated Intensity Modulated Radiation Therapy for Locally Advanced Head and Neck Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-03-13"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.